Cockburn J, Staples M, Hurley S F, De Luise T
Centre for Behavioural Research in Cancer, Anti-Cancer Council of Victoria, Australia.
J Med Screen. 1994 Jan;1(1):7-12. doi: 10.1177/096914139400100104.
To examine the psychological consequences at a number of stages in the screening process for women attending a screening mammography programme.
A pilot mammographic screening programme in Melbourne, Australia.
The psychological consequences questionnaire (PCQ; a reliable and valid measure of the psychological consequences of screening mammography) was used to measure the emotional, social, and physical functioning of women in a mammographic screening programme and a control community sample. A screening group (in whom no abnormality was detected at initial screen; n = 142) had four measurements: at screening clinic; before results were received; one week after all-clear results were received; and eight months after initial visit. The recall group (who were recalled for further investigation which showed the detected abnormality to be benign; n = 58) had measurements at the same points as the screening group and an additional measurement while waiting at the recall assessment clinic. A randomly selected community control group (n = 52) had measurements one week, two weeks, three weeks, and eight months after consenting to participate.
Emotional, social, and physical functioning of women in the screening group did not change over time and at no point differed significantly from that of community controls. The profiles of emotional and physical dysfunction of women in the recall group differed significantly from those of the screening and control groups. The level of emotional and physical dysfunction in the recall group was highest while waiting at recall assessment clinic, and scores were still significantly higher than scores obtained at comparable times from screening and control groups one week after obtaining notification that there was no sign of cancer (emotional P < 0.001; physical P < 0.05). This difference had disappeared eight months after the screening visit, when the level of emotional and physical functioning was similar to that of the screening and control groups. Social dysfunction scores did not change significantly over time and were similar for all three groups.
Given that up to 10% of women are recalled for further investigations on first round screening, significant numbers of women may have psychological consequences. This speaks for the necessity for accurate reading of mammograms to minimise the false positive recall rate, and for counselling services to be available at recall assessment centres.
研究参加乳腺钼靶筛查项目的女性在筛查过程中多个阶段的心理影响。
澳大利亚墨尔本的一项乳腺钼靶筛查试点项目。
采用心理影响问卷(PCQ,一种可靠且有效的测量乳腺钼靶筛查心理影响的工具)来评估乳腺钼靶筛查项目中的女性以及对照社区样本的情绪、社交和身体功能。筛查组(初始筛查未发现异常;n = 142)进行了四次测量:在筛查诊所、收到结果前、收到全部正常结果一周后以及初次就诊八个月后。召回组(被召回进一步检查,检查显示检测到的异常为良性;n = 58)在与筛查组相同的时间点进行测量,并且在召回评估诊所等待时进行了额外测量。随机选择的社区对照组(n = 52)在同意参与后的一周、两周、三周和八个月进行测量。
筛查组女性的情绪、社交和身体功能随时间没有变化,且在任何时间点与社区对照组相比均无显著差异。召回组女性的情绪和身体功能障碍情况与筛查组和对照组有显著差异。召回组的情绪和身体功能障碍水平在召回评估诊所等待时最高,并且在收到无癌症迹象通知一周后,其得分仍显著高于筛查组和对照组在相应时间获得的得分(情绪方面P < 0.001;身体方面P < 0.05)。在筛查就诊八个月后,这种差异消失,此时情绪和身体功能水平与筛查组和对照组相似。社交功能障碍得分随时间没有显著变化,三组相似。
鉴于在首轮筛查中有高达10%的女性被召回进一步检查,大量女性可能会有心理影响。这表明有必要准确解读乳腺钼靶片以尽量降低假阳性召回率,并且召回评估中心需要提供咨询服务。